Reaction

Hypoparathyroidism reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 755 reports · 25 co-occurring drugs

As of the last recalculation, Hypoparathyroidism appears in 755 FAERS reports alongside 25 co-occurring drug terms. The strongest observed disproportionality signal is CALCITRIOL CAPSULES 0.25 MCG (PRR 101.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Calcitriol Capsules 0.25 Mcg67101.0101.4
Calcitriol Capsules 0.5 Mcg67101.0101.4
Calcitriol6799.9100.2
Nebivolol2952.252.2
Calcium Gluconate2149.449.5
Antacid4829.729.7
Rabeprazole2329.529.5
Febuxostat Tablets 40 Mg1027.527.5
Febuxostat Tablets 80 Mg1027.527.5
Cortisone Acetate1227.227.2
Itraconazole1126.326.4
Gentamicin1225.725.7
Magnesium Hydroxide1224.924.9
Nebivolol Hydrochloride2924.624.6
Haloperidol2023.323.3
Haloperidol Lactate2022.922.9
Gentamicin Sulfate1221.321.3
Buspirone Hydrochloride820.220.2
Dextrose919.119.1
Dextrose Monohydrate918.818.8
Febuxostat1016.716.7
Lanreotide Acetate414.114.1
Cinacalcet Hydrochloride1911.511.5
Ipilimumab127.87.8
Romosozumab-Aqqg36.16.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.